WebDisclosure WebDisclosure
Basculer en Français
10793 Companies
233162 Keywords
161769 Articles
124378 Press releases
Headlines Articles Press releases Lindis Blood Care GmbH Remove
  1. Home
  2. Companies
  3. Lindis Blood Care GmbH
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/11/2024 at 14:05, 2 years 3 months ago

    Lindis Blood Care dévoilera les résultats de l'étude REMOVE sur CATUVAB® lors du symposium NATA24

    CATUVAB® Soins Du Sang Lindis SUPPRIMER L'étude Symposium NATA24 Chirurgie Du Cancer
  • PRESS RELEASE

    published on 04/11/2024 at 14:00, 2 years 3 months ago

    Lindis Blood Care to Present Top Line Results from Clinical Certification Study REMOVE with CATUVAB® at NATA24 Annual Symposium

    Lindis Blood Care to Present Top Line Results from Clinical Certification Study REMOVE with CATUVAB at NATA24 Annual Symposium in Bologna, Italy. Prof. Dr. med. Patrick Meybohm to present safety and efficacy data
    Lindis Blood Care CATUVAB NATA24 Annual Symposium Clinical Certification Study Tumor Cells
    Logo of Lindis Blood Care GmbH
Previous page
1 2
Accesswire
  • Published on 08/01/2026 at 01:58, 4 hours 46 minutes ago

    Clôture de l'option sur la propriété de graphite au Québec

  • Published on 08/01/2026 at 01:20, 5 hours 24 minutes ago

    Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage

  • Published on 08/01/2026 at 01:15, 5 hours 29 minutes ago

    Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination

  • Published on 08/01/2026 at 00:30, 6 hours 14 minutes ago

    Battery X Metals Announces Amendment to Corporate Awareness Engagement

  • Published on 08/01/2026 at 00:25, 6 hours 19 minutes ago

    BioNxt Solutions Announces Option Grants

View all ACCESSWIRE
EQS Group
  • Published on 07/31/2026 at 19:55, 10 hours 49 minutes ago

    EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process

  • Published on 07/31/2026 at 19:05, 11 hours 39 minutes ago

    Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project

  • Published on 07/31/2026 at 18:55, 11 hours 49 minutes ago

    Holding(s) in Company

  • Published on 07/31/2026 at 18:53, 11 hours 50 minutes ago

    Deutsche EuroShop SE: Conversion into a European Company Successfully Completed

  • Published on 07/31/2026 at 18:40, 12 hours 4 minutes ago

    EQS-Adhoc: VIB Vermögen AG: Lock-Up Agreements with noteholders and promissory noteholders of BRANICKS Group AG have become fully effective

View all EQS
Les Echos
  • Published on 07/31/2026 at 21:00, 9 hours 44 minutes ago

    Carrefour finalise la vente de sa participation minoritaire dans CarrefourSA en Turquie à Yeni Mağazacılık A.Ş., société opérant l'enseigne de A101 et contrôlée par le Groupe Aydın

  • Published on 07/31/2026 at 21:00, 9 hours 44 minutes ago

    Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group

  • Published on 07/31/2026 at 19:27, 11 hours 17 minutes ago

    Share retention commitments (Dutreil Agreement)

  • Published on 07/31/2026 at 19:27, 11 hours 17 minutes ago

    Engagements de conservation d’actions (Pacte Dutreil)

  • Published on 07/31/2026 at 19:14, 11 hours 30 minutes ago

    2026 First-Half financial report

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy